Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on ...

Shoppers will have to act fast to get their hands on the 'luxurious' moisturiser which is on sale now but there are limited ...

Shoppers will have to act fast to get their hands on the 'luxurious' moisturiser with limited stocks available.

Fintel reports that on September 24, 2024, TD Cowen initiated coverage of Protagonist Therapeutics (NasdaqGM:PTGX) with a Buy ...

Almost half of women will be affected by hair loss throughout their lives, according to The Royal Australian College of ...

A pioneering study, presented today at the EADV Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in ...

If you're chronically online, you're probably obsessed with Moo Deng.. and her glass skin. In honor of her glow, here are 11 ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Anti-obesity medication is emerging as the latest pharma megatrend. However, the increasing demand for these semaglutide ...

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, today announced the U.S. Food and Drug Administration (FDA) approval for ...

Several physicians said newer monoclonal antibodies to treat migraine should be first in defense for primary care clinicians.